Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $350K invested in Processa Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $691K → $350K (-$342K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$31.6K | |
| 2 | +$20K | |
| 3 | +$17.6K | |
| 4 |
HF
HRT Financial
New York
|
+$7.37K |
| 5 |
Renaissance Technologies
New York
|
+$3.21K |
Top Sellers
| 1 | -$44.2K | |
| 2 | -$14K | |
| 3 | -$9.96K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.42K |
| 5 |
VF
Virtu Financial
New York
|
-$5.67K |